Trial Profile
A trial of abuse-resistant formulation of hydromorphone for treatment of pain
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 11 Jul 2019
Price :
$35
*
At a glance
- Drugs Hydromorphone (Primary)
- Indications Pain
- Focus Adverse reactions
- 27 May 2015 New trial record